Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TD-1792 vs Vancomycin in cSSSI
NCT00442832Phase 2Completed
- Sponsor
- Theravance Biopharma, Inc.
- Start
- Dec 2006
- Primary completion
- May 2007
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cefilavancin in Skin and Skin Structure Infection (SSSI), sponsored by Theravance Biopharma, Inc.. Started Dec 2006; status: completed.
02
Drugs
cefilavancin
03
Conditions
Skin and Skin Structure Infection (SSSI)
Beyond the preview
Go deeper on NCT00442832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00442832.